Envonalkib citrate

Cat. No.: IBDI-437906

Envonalkib citrate is a potent and orally active inhibitor of ALK, with IC50s of 1.96 nM, 35.1 nM, and 61.3 nM for WT and mutated L1196M and G1269S-ALK. Envonalkib citrate can be used for the research of non-small cell lung cancer.

Product Details

Target	Anaplastic lymphoma kinase (ALK)
Molecular Weight	698.52
SMILES	OC(CC(C(O)=O)(O)CC(O)=O)=O.COC1=CC(N2[[email protected]](CNCC2)C)=NC=C1C3=CN=C(N)C(O[[email protected]@H](C4=C(C(F)=CC=C4Cl)Cl)C)=C3

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.